None provided


The following timeline graph is generated from all co-authored publications.

Featured publications are shown below:

  1. Peripherally Delivered Hepatopreferential Insulin Analog Insulin-406 Mimics the Hypoglycemia-sparing Effect of Portal Vein Human Insulin Infusion in Dogs. Gregory JM, Kraft G, Scott MF, Neal DW, Farmer B, Smith MS, Hastings JR, Madsen P, Kjeldsen TB, Hostrup S, Brand CL, Fledelius C, Nishimura E, Cherrington AD (2019) Diabetes Obes Metab
    › Primary publication · 31183936 (PubMed)
  2. A New Animal Model of Insulin-Glucose Dynamics in the Intraperitoneal Space Enhances Closed-Loop Control Performance. Chakrabarty A, Gregory JM, Moore LM, Williams PE, Farmer B, Cherrington AD, Lord P, Shelton B, Cohen D, Zisser HC, Doyle FJ, Dassau E (2019) J Process Control : 62-73
    › Primary publication · 31178632 (PubMed) · PMC6548466 (PubMed Central)
  3. Iatrogenic Hyperinsulinemia, Not Hyperglycemia, Drives Insulin Resistance in Type 1 Diabetes as Revealed by Comparison to GCK-MODY (MODY2). Gregory JM, Smith TJ, Slaughter JC, Mason HR, Hughey CC, Smith MS, Kandasamy B, Greeley SAW, Philipson LH, Naylor RN, Letourneau LR, Abumrad NN, Cherrington AD, Moore DJ (2019) Diabetes
    › Primary publication · 31092478 (PubMed)
  4. Medical and Psychological Considerations for Carbohydrate-Restricted Diets in Youth With Type 1 Diabetes. Gallagher KAS, DeSalvo D, Gregory J, Hilliard ME (2019) Curr Diab Rep 19(6): 27
    › Primary publication · 31030356 (PubMed)
  5. Enterically delivered insulin tregopil exhibits rapid absorption characteristics and a pharmacodynamic effect similar to human insulin in conscious dogs. Gregory JM, Lautz M, Moore LM, Williams PE, Reddy P, Cherrington AD (2019) Diabetes Obes Metab 21(1): 160-169
    › Primary publication · 30095210 (PubMed) · PMC6281755 (PubMed Central)
  6. Glucose autoregulation is the dominant component of the hormone-independent counterregulatory response to hypoglycemia in the conscious dog. Gregory JM, Rivera N, Kraft G, Winnick JJ, Farmer B, Allen EJ, Donahue EP, Smith MS, Edgerton DS, Williams PE, Cherrington AD (2017) Am J Physiol Endocrinol Metab 313(3): E273-E283
    › Primary publication · 28512154 (PubMed) · PMC5625082 (PubMed Central)
  7. Hepatic glycogen can regulate hypoglycemic counterregulation via a liver-brain axis. Winnick JJ, Kraft G, Gregory JM, Edgerton DS, Williams P, Hajizadeh IA, Kamal MZ, Smith M, Farmer B, Scott M, Neal D, Donahue EP, Allen E, Cherrington AD (2016) J Clin Invest 126(6): 2236-48
    › Primary publication · 27140398 (PubMed) · PMC4887181 (PubMed Central)
  8. Insulin Delivery Into the Peripheral Circulation: A Key Contributor to Hypoglycemia in Type 1 Diabetes. Gregory JM, Kraft G, Scott MF, Neal DW, Farmer B, Smith MS, Hastings JR, Allen EJ, Donahue EP, Rivera N, Winnick JJ, Edgerton DS, Nishimura E, Fledelius C, Brand CL, Cherrington AD (2015) Diabetes 64(10): 3439-51
    › Primary publication · 26085570 (PubMed) · PMC4587648 (PubMed Central)
  9. Type 1 diabetes mellitus. Gregory JM, Moore DJ, Simmons JH (2013) Pediatr Rev 34(5): 203-15
    › Primary publication · 23637249 (PubMed)
  10. Can technological solutions for diabetes replace islet cell function? Gregory JM, Moore DJ (2011) Organogenesis 7(1): 32-41
    › Primary publication · 21289480 (PubMed) · PMC3082032 (PubMed Central)
  11. Mitigating micro-and macro-vascular complications of diabetes beginning in adolescence. Moore DJ, Gregory JM, Kumah-Crystal YA, Simmons JH (2009) Vasc Health Risk Manag : 1015-31
    › Primary publication · 19997571 (PubMed) · PMC2788594 (PubMed Central)